» Articles » PMID: 9041903

Parkinson's Disease: an Investigation of Exercise Capacity, Respiratory Function, and Gait

Overview
Date 1997 Feb 1
PMID 9041903
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the exercise capacity of subjects with mild to moderate Parkinson's disease and determine whether abnormalities in respiratory function and gait affect exercise capacity.

Design: Descriptive. Subjects were categorized according to exercise history, disease severity, and presence/absence of upper airway obstruction.

Subjects And Setting: Sixteen volunteers with mild to moderate idiopathic Parkinson's disease attended a university research laboratory.

Main Outcome Measures: Subjects performed a maximum exercise test on a cycle ergometer, together with respiratory function tests and a walking test. Peak values for oxygen consumption and work rate were recorded for the maximum exercise test. Measures of respiratory function included spirometry, flow-volume loops, lung volumes, and mouth pressures. Velocity, stride length, and cadence were measured for preferred and fast speeds of walking. The values obtained on each of these tests were compared with published predicted age- and gender-matched normal values.

Results: Peak oxygen consumptions and peak work loads achieved by subjects with Parkinson's disease were not significantly different from normal values, despite evidence of respiratory and gait abnormalities typical of Parkinson's disease. Exercise category was significantly correlated with percent predicted VO2peak (r = .64, p < .01), with sedentary subjects producing lower scores than exercising subjects. There was no significant correlation between disease severity and percent predicted VO2peak.

Conclusion: Despite their neurological deficit, individuals with mild to moderate Parkinson's disease have the potential to maintain normal exercise capacity with regular aerobic exercise.

Citing Articles

Exercise Intolerance and Oxygen Desaturation in Patients with Parkinson's Disease: Triggers for Respiratory Rehabilitation?.

Vitacca M, Olivares A, Comini L, Vezzadini G, Langella A, Luisa A Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886018 PMC: 8656612. DOI: 10.3390/ijerph182312298.


The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.

Kambey P, Chengcheng M, Xiaoxiao G, Abdulrahman A, Kanwore K, Nadeem I Metab Brain Dis. 2021; 36(4):609-625.

PMID: 33507465 DOI: 10.1007/s11011-021-00670-2.


The Proprioceptive Neuromuscular Facilitation Concept in Parkinson Disease: A Systematic Review and Meta-Analysis.

Assis I, Luvizutto G, Bruno A, De Souza L J Chiropr Med. 2020; 19(3):181-187.

PMID: 33362441 PMC: 7750824. DOI: 10.1016/j.jcm.2020.07.003.


Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson's disease.

Jeng B, Cederberg K, Lai B, Sasaki J, Bamman M, Motl R Gait Posture. 2020; 82:1-5.

PMID: 32836026 PMC: 7718302. DOI: 10.1016/j.gaitpost.2020.08.108.


Combining a Cognitive Concurrent Task with a Motor or Motor-Cognitive Task: Which Is Better to Differentiate Levels of Affectation in Parkinson's Disease?.

Pereiro A, Resua B, Facal D, Cancela-Carral J Parkinsons Dis. 2020; 2020:2189084.

PMID: 32322384 PMC: 7160727. DOI: 10.1155/2020/2189084.